Clinical Trials Logo

Skin Cancer clinical trials

View clinical trials related to Skin Cancer.

Filter by:

NCT ID: NCT02824289 Completed - Skin Cancer Clinical Trials

Sun Safe Workplaces: A Campaign on Sun Protection Policies for Outdoor Workers

SSW
Start date: July 1, 2009
Phase: N/A
Study type: Interventional

A sample of local government organizations are recruited to a group-randomized pretest-posttest controlled trial evaluating the effect of a campaign to promote workplace policy and education on sun protection for outdoor workers. Primary outcome is adoption of formal policies and secondary outcomes are implementation of policy and sun protection practices by outdoor workers.

NCT ID: NCT02721459 Active, not recruiting - Melanoma Clinical Trials

XL888 + Vemurafenib + Cobimetinib for Unresectable BRAF Mutated Stage III/IV Melanoma

Start date: September 7, 2016
Phase: Phase 1
Study type: Interventional

The main purpose of this study is to determine the maximum tolerated dose (MTD) and recommended phase II dose (RP2D) of XL888 when administered orally with vemurafenib plus cobimetinib in participants with BRAF V600 mutated melanoma and to evaluate the safety and tolerability of this combination.

NCT ID: NCT02704039 Completed - Skin Cancer Clinical Trials

Multimodal Spectroscopy (MMS) for in Vivo Noninvasive Assessment of Skin

Start date: January 2016
Phase:
Study type: Observational

The goal of this research program is to develop a simple, noninvasive diagnostic device for assessing skin pathology without the need for a biopsy. The device being studied is a single system capable of collecting three spectroscopy measurements (Raman, diffuse reflectance and laser induced fluorescence spectroscopy) from skin lesion sites. In order to accomplish this objective, the investigators propose to: 1) develop biophysical model for Raman spectroscopy of skin cancers, 2) conduct a clinical pilot study to collect MMS data from a minimum of 250 patients to determine the diagnostic accuracy (sensitivity and specificity) of MMS for diagnosing skin malignancy.

NCT ID: NCT02652455 Completed - Melanoma (Skin) Clinical Trials

Combining PD-1 Blockade, CD137 Agonism and Adoptive Cell Therapy for Metastatic Melanoma

Start date: March 8, 2016
Phase: Early Phase 1
Study type: Interventional

The purpose of this Pilot Study is to investigate the safety, side effects, and benefits of tumor- infiltrating lymphocytes (TILs) when they are given with the drug nivolumab. Nivolumab is a type of immunotherapy - a drug that is used to boost the ability of the immune system to fight cancer, infection, and other diseases. The primary endpoints of this pilot trial will be the safety and feasibility of the treatment regimens.

NCT ID: NCT02583815 Completed - Breast Cancer Clinical Trials

Feasibility of Activity Monitoring in Patients With Cancer: Physical Activity Monitoring in Cancer Patients (PAMCaP)

PAMCap
Start date: August 2015
Phase:
Study type: Observational

This is an open label feasibility pilot study of commercially available physical activity monitoring devices in patients receiving systemic therapy at the Harold Simmons Cancer Center, UT Southwestern Medical Center.

NCT ID: NCT02395562 Completed - Skin Cancer Clinical Trials

Viral Reactivation and Skin Cancer

Start date: January 2008
Phase: N/A
Study type: Observational

Several studies show that the incidence of skin cancer parallels the length and depth of immunosuppression. This study will analyze the correlation of viral reactivation and skin cancer in organ transplant recipients.

NCT ID: NCT02361229 Active, not recruiting - Skin Cancer Clinical Trials

Skin Cancer in Swiss Transplant Cohort Study

SCSTCS
Start date: January 2008
Phase:
Study type: Observational [Patient Registry]

It's known that organ transplant recipients with long-term drug-induced immunosuppression have a increase of the life-time incidence of squamous cell carcinoma. This study will analyze the incidence and type of skin cancer in the Swiss Transplant Cohort Study and the association with exposure to immunosuppressive and antiinfective drugs and other parameters like age or gender of organ transplant recipients.

NCT ID: NCT02244749 Completed - Skin Cancer Clinical Trials

Role of Metabolic Enzymes in Non-Melanoma Skin Cancer

Start date: March 2011
Phase:
Study type: Observational

The researcher can proved that certain compounds play an important role in the prevention of skin cancer. Researcher can use specific compounds, which classified as metabolic enzymes, and lower concentrations and complete absent in skin cancer cells. Researcher can biopsies of normal skin and precancerous or cancerous lesions, and can compare the concentrations of these compounds to determine the difference between the two areas. The result can lead to further understanding of skin cancers and pre-cancers. Because skin cancers and pre-cancers are so common, any knowledge would be very useful for many people in the future and may be used for development of future treatments or prevention strategies.

NCT ID: NCT02235116 Completed - Skin Cancer Clinical Trials

Predictors of Patient Attitudes and Barriers to Skin Cancer Screening

Start date: June 2011
Phase:
Study type: Observational

This is a cross-sectional survey distributed to a convenience sample of patients in a waiting room of an academic dermatology clinic. The survey assesses patient experiences with full body skin exams and attitudes towards full body skin exams. The survey is designed to help investigators better understand how many patients are not getting full body skin exams, why this may be occurring, and what types of interventions may be enacted to increase the number of patients getting full body skin exams.

NCT ID: NCT02192918 Completed - Skin Cancer Clinical Trials

Pilot Investigation of Behavioral Alternatives to Indoor Tanning

Start date: April 2012
Phase: N/A
Study type: Interventional

The goal of this research is to develop and test the feasibility of an intervention that stimulates uptake of healthy alternatives to tanning by providing free access to them for a limited time. Free access gives participants a low-risk opportunity to try something new that is consistent with their motivations. Free access also allows them to experience the reinforcing properties of the alternatives which could prime continued use after the free trial period. The objective of the present study is to determine the feasibility and short-term efficacy of providing free alternatives to indoor tanners in an effort to "nudge" them to switch from indoor tanning to healthy alternatives.